Table 1 Characteristics of the population who were enrolled at baseline and who concluded the study
Total population | Enrolled (n = 914) | Concluding the study (n = 816) | ||||
|---|---|---|---|---|---|---|
Groups | NO ICS (n = 368) | ICS (n = 546) | p-value | NO ICS (n = 334) | ICS (n = 482) | p-value |
Gender (%F) | 30% | 27% | 0.4102 | 30% | 27% | 0.2817 |
Age (Yrs) | 72.0 (9.5) | 72.8 (9.1) | 0.1750 | 72.1 (9.2) | 73.0 (8.9) | 0.1936 |
BMI | 27.6 (5.1) | 28.3 (5.1) | 0.0600 | 27.8 (5.1) | 28.4 (5.1) | 0.1458 |
Smoking history° (%Y) | 82% | 91% | 0.0007 | 83% | 91% | 0.0019 |
Ex-smokers | 60% | 69% | 0.0047 | 60% | 68% | 0.0187 |
Smokers | 22% | 22% | 1.0000 | 23% | 23% | 1.0000 |
Years since diagnosis | 6.8 (6.7) | 6.6 (6.0) | 0.5401 | 6.8 (6.6) | 6.6 (6.0) | 0.6794 |
VC (%pred) | 91.5 (15.9) | 95.2 (19.5) | 0.0054 | 91.4 (15.7) | 94.7 (18.6) | 0.0124 |
FEV 1 (%pred) | 71.7 (10.4) | 70.8 (11.3) | 0.2608 | 71.6 (10.5) | 71.1 (11.4) | 0.5293 |
FEV 1 /VC | 0.60 (0.08) | 0.59 (0.08) | 0.2679 | 0.60 (0.08) | 0.59 (0.08) | 0.1865 |
CAT | 15.9 (8.5) | 14.8 (7.8) | 0.0717 | 16.0 (8.6) | 14.8 (7.8) | 0.0528 |
Exacerbations (0/1) | 135/233 | 206/340 | 0.802 | 127/207 | 186/296 | 0.928 |
Comorbidities: 0 | 116 (32%) | 130 (24%) | 0.012 | 102 (30%) | 109 (23%) | 0.285 |
Comorbidities: 1 | 110 (30%) | 174 (32%) | 0.575 | 101 (30%) | 153 (32%) | 0.800 |
Comorbidities: ≥2 | 142 (38%) | 242 (44%) | 0.088 | 131 (40%) | 220 (45%) | 0.390 |